National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
70.84
-0.63 (-0.88%)
Jun 27, 2025, 4:00 PM - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
The 4 analysts that cover National Health Investors stock have a consensus rating of "Buy" and an average price target of $85.75, which forecasts a 21.05% increase in the stock price over the next year. The lowest target is $77 and the highest is $92.
Price Target: $85.75 (+21.05%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Buy | 4 | 4 | 2 | 2 | 2 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $76 → $77 | Hold | Maintains | $76 → $77 | +8.70% | Jun 9, 2025 |
Truist Securities | Truist Securities | Hold Maintains $70 → $76 | Hold | Maintains | $70 → $76 | +7.28% | Mar 19, 2025 |
Wedbush | Wedbush | Buy Reiterates $88 | Buy | Reiterates | $88 | +24.22% | Mar 17, 2025 |
Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | +1.64% | Dec 23, 2024 |
Wells Fargo | Wells Fargo | Buy → Hold Initiates $81 → $86 | Buy → Hold | Initiates | $81 → $86 | +21.40% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
358.96M
from 335.58M
Increased by 6.97%
Revenue Next Year
397.38M
from 358.96M
Increased by 10.70%
EPS This Year
3.11
from 3.13
Decreased by -0.48%
EPS Next Year
3.32
from 3.11
Increased by 6.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 416.8M | 512.5M | 601.7M | ||
Avg | 359.0M | 397.4M | 432.3M | ||
Low | 328.3M | 343.8M | 345.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 24.2% | 42.8% | 51.4% | ||
Avg | 7.0% | 10.7% | 8.8% | ||
Low | -2.2% | -4.2% | -13.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3.35 | 3.61 | 3.63 |
Avg | 3.11 | 3.32 | 3.39 |
Low | 2.95 | 3.12 | 3.20 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 7.0% | 16.0% | 9.3% |
Avg | -0.5% | 6.7% | 1.9% |
Low | -5.8% | 0.1% | -3.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.